Vaping in Pregnancy: Unraveling Molecular Drivers of Preeclampsia and Fetal Growth Restriction
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010009 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Archarlie Chou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Pre-Eclampsia, Vaping. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Preeclampsia (PE) and intrauterine growth restriction (IUGR) are major pregnancy complications that are linked to placental dysfunction and environmental stimulation such as the use of electronic cigarettes (eCig). This study investigates the molecular impacts of timed eCig exposure in a C57BL/6 mouse model of PE and IUGR using bulk RNA-sequencing of placental tissues. Pregnant mice were exposed to eCig vapor via nose-only system starting at embryonic day 12.5 (eCig-6d, before spiral artery (SA) invasion) or 14.5 (eCig-4d, after SA invasion) until E18.5 (necropsy), with healthy controls exposed to room air (n = 6/group). The eCig-4d group developed PE, whereas the eCig-6d group developed both PE and IUGR. RNA-seq analysis revealed 429 differentially expressed genes (DEGs) in eCig-4d (IUGR-like) group and 64 DEGs in eCig-6d (PE + IUGR-like) group compared to controls. Pathway and gene network analyses indicated that eCig-4d exposure activated NF-κB–driven inflammation, suppressed ECM organization and collagen biosynthesis, and downregulated vasoactive genes/mitochondrial-associated genes (NOS1/2), accompanied by impaired complement initiation and reduced both macrophage and monocyte signals. Similarly, eCig-6d exposure led to downregulation of complement-associated genes and granule-related components, possibly implicating weakened neutrophil responsiveness and compromised inflammatory resolution at the maternal–fetal interface. Our findings align with prior studies on physiological dysfunctions in PE and IUGR, while also providing novel insights into the temporally specific cellular responses induced by eCig exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA.
- Department of Cell Biology and Physiology, Brigham Young University, 3052 LSB, Provo, UT 84602, USA.
ORCID-Profile: Paul R Reynolds, Brett E Pickett, Juan A Arroyo
Förderung
- NICHD NIH HHS
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Chou, A., Hiatt, O., Davidson, B., Reynolds, P. R., Pickett, B. E., & Arroyo, J. A. (2025). Vaping in Pregnancy: Unraveling Molecular Drivers of Preeclampsia and Fetal Growth Restriction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010009
Vancouver
Chou A, Hiatt O, Davidson B, Reynolds PR, Pickett BE, Arroyo JA. Vaping in Pregnancy: Unraveling Molecular Drivers of Preeclampsia and Fetal Growth Restriction. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010009
BibTeX
@article{Chou2025,
author = {Chou, Archarlie and Hiatt, Olivia and Davidson, Benjamin and Reynolds, Paul R and Pickett, Brett E and Arroyo, Juan A},
title = {Vaping in Pregnancy: Unraveling Molecular Drivers of Preeclampsia and Fetal Growth Restriction},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010009}
}
EUVIMED